Quantitative determination of nalbuphine in plasma using eletron-capture detection
β Scribed by Stephen H. Weinstein; Miryam Alteras; Janet Gaylord
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 203 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
β¦ Synopsis
A procedure for the determination of nalbuphine in plasma is presented. The compound and an internal standard are extracted into benzene-2-propanol from plasma at pH 10.4, followed by back-extraction into 0.1 N HCl. After the acid phase is washed with benzene and the compound is reextracted into benzene-2-propanol, the heptafluorobutyryl derivatives are formed and determined using electron-capture GLC. The lower limit of sensitivity is approximately 0.5 ng/ml, and the upper limit of the linear dynamic range is greater than 50 ng/ml. Peak plasma levels of 50 and 150 ng were observed in two dogs 10 and 20 min, respectively, after subcutaneous administration of 1 mg of nalbuphine/kg. Nalbuphine was detectable in plasma 5 hr after administration.
π SIMILAR VOLUMES
A rapid, sensitive, and reliable method for the determination of nifedipine in human plasma is described. Using a single-step solvent extraction and capillary gas chromatography combined with electron capturedetection, an assaysensitivityof 2 ng/ml is achieved routinely using 0.5 ml of plasma. Intac
A rapid sensitive and selective isocratic technique was developed for the analysis of plasma epirubicin and three of its known fluorescent metabolites epirubicinol, 4'-O-~-~-glucuronyl-4'-epidoxorubicin and 4'-O-fi-D-ghCUrOnyl 1,3-dihydro-4'-epidoxorubicin, with daunorubicin as an internal standard,
## Abstract A sensitive GCβECD assay has been developed for the simultaneous determination of midazolam (I) and its Ξ±βhydroxy metabolite (II) in plasma. The assay involves extraction of both compounds into ether at alkaline pH (pH 12), followed by silylation of the Ξ±βhydroxy metabolite with N,Oβbis